The approval periods of the active substances amidosulfuron, bifenox, clofentezine, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, lenacil, nicosulfuron, picloram and pyriproxyfen were extended until 31 December 2019 by Implementing Regulation (EU) 2018/1796.
Recital 4, Regulation (EU) 2019/1589
In forcesince 26 Sep 2019